Aurum Ventures M.K.I

Aurum Ventures M.K.I is a Ramat Gan, Israel-based growth capital firm founded in 2005 as the venture capital vehicle of Morris Kahn, the prominent Israeli businessman and philanthropist who served as former chairman of Amdocs. The firm provides value-added capital to exceptional entrepreneurs in life sciences and clean technology, investing primarily at Series A, B, and later stages in companies with demonstrated clinical or commercial traction. Aurum has invested in 15 companies across biotech, clean tech, health technology, and pharma, with notable portfolio companies including LifeBond, Nephera, and BPT. The firm leads rounds with checks typically between $3 million and $20 million. Over its history, 55 co-investors have participated in Aurum's portfolio companies, including institutional names such as TELUS Ventures, RA Capital Management, and BlackRock — a reflection of the caliber of deal flow the firm sources. Aurum Ventures' core competitive advantage is the network, credibility, and industry relationships that come with the backing of Morris Kahn — one of Israel's most respected business leaders. Portfolio companies benefit from strategic guidance grounded in decades of operating and investing experience in the Israeli and global technology landscape. The firm's focus on life sciences and clean tech positions it at the intersection of two sectors where Israel has developed notable scientific and engineering depth, and where patient, relationship-driven capital creates meaningful differentiation at growth stage.